<DOC>
	<DOCNO>NCT02238223</DOCNO>
	<brief_summary>Study investigate safety efficacy information Alesion速 Tablet proper use daily clinical practice new treatment guideline allergic rhinitis , bronchial asthma , eczema , dermatitis , urticaria , pruritus , prurigo psoriasis vulgaris itch</brief_summary>
	<brief_title>Postmarketing Surveillance Investigate Safety Efficacy Information Alesion速 Tablet</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Epinastine</mesh_term>
	<criteria>All patient : n't treatment experience epinastine product ; least one follow disease . allergic rhinitis , eczema , dermatitis , pruritus , prurigo , urticaria , psoriasis itching , bronchial asthma Alesion速 Tablet contraindicate patient history hypersensitivity ingredient Alesion速 Tablet package insert . However , unknown whether patient hypersensitive ingredient product almost case . And survey drug utilization study observe actual use patient . Therefore exclusion criterion set protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>